Abingdon Health Plc Stock OTC Markets

Equities

ABDXF

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:32:19 2022-08-19 EDT 5-day change 1st Jan Change
0.07 USD -.--% Intraday chart for Abingdon Health Plc -.--% -.--%

Financials

Sales 2022 2.84M 3.61M 4.95M Sales 2023 4.04M 5.14M 7.06M Capitalization 36.95M 47M 64.46M
Net income 2022 -21M -26.71M -36.63M Net income 2023 -3M -3.82M -5.23M EV / Sales 2022 11.6 x
Net cash position 2022 1.12M 1.42M 1.95M Net cash position 2023 2.22M 2.82M 3.87M EV / Sales 2023 8.59 x
P/E ratio 2022
-1.57 x
P/E ratio 2023
-10.5 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.95%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder 50 08-01-15
Founder 63 08-01-15
Director of Finance/CFO - 23-10-23
Members of the board TitleAgeSince
Founder 63 08-01-15
Director/Board Member 62 20-10-25
Founder 50 08-01-15
More insiders
Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.
More about the company